175 related articles for article (PubMed ID: 31508359)
1. PARK2 Suppresses Proliferation and Tumorigenicity in Non-small Cell Lung Cancer.
Duan H; Lei Z; Xu F; Pan T; Lu D; Ding P; Zhu C; Pan C; Zhang S
Front Oncol; 2019; 9():790. PubMed ID: 31508359
[No Abstract] [Full Text] [Related]
2. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-338-3p suppresses cell proliferation and induces apoptosis of non-small-cell lung cancer by targeting sphingosine kinase 2.
Zhang G; Zheng H; Zhang G; Cheng R; Lu C; Guo Y; Zhao G
Cancer Cell Int; 2017; 17():46. PubMed ID: 28428733
[TBL] [Abstract][Full Text] [Related]
4. Interferon Consensus Sequence-Binding Protein 8, a Tumor Suppressor, Suppresses Tumor Growth and Invasion of Non-Small Cell Lung Cancer by Interacting with the Wnt/β-Catenin Pathway.
Ye L; Xiang T; Zhu J; Li D; Shao Q; Peng W; Tang J; Li L; Ren G
Cell Physiol Biochem; 2018; 51(2):961-978. PubMed ID: 30466106
[TBL] [Abstract][Full Text] [Related]
5. Long Noncoding RNA FAL1 Promotes Cell Proliferation, Invasion and Epithelial-Mesenchymal Transition Through the PTEN/AKT Signaling Axis in Non-Small Cell Lung Cancer.
Pan C; Yao G; Liu B; Ma T; Xia Y; Wei K; Wang J; Xu J; Chen L; Chen Y
Cell Physiol Biochem; 2017; 43(1):339-352. PubMed ID: 28854421
[TBL] [Abstract][Full Text] [Related]
6. Leukocyte Cell-Derived Chemotaxin 2 Retards Non-Small Cell Lung Cancer Progression Through Antagonizing MET and EGFR Activities.
Hung WY; Chang JH; Cheng Y; Chen CK; Chen JQ; Hua KT; Cheng CW; Hsiao M; Chung CL; Lee WJ; Chien MH
Cell Physiol Biochem; 2018; 51(1):337-355. PubMed ID: 30453282
[TBL] [Abstract][Full Text] [Related]
7. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
8. Effects of insulin-like growth factor binding protein-3 and farnesyltransferase inhibitor SCH66336 on Akt expression and apoptosis in non-small-cell lung cancer cells.
Lee HY; Moon H; Chun KH; Chang YS; Hassan K; Ji L; Lotan R; Khuri FR; Hong WK
J Natl Cancer Inst; 2004 Oct; 96(20):1536-48. PubMed ID: 15494604
[TBL] [Abstract][Full Text] [Related]
9. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway.
Gao BB; Wang SX
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1093-1101. PubMed ID: 30779077
[TBL] [Abstract][Full Text] [Related]
10. Desmoglein-2 is overexpressed in non-small cell lung cancer tissues and its knockdown suppresses NSCLC growth by regulation of p27 and CDK2.
Cai F; Zhu Q; Miao Y; Shen S; Su X; Shi Y
J Cancer Res Clin Oncol; 2017 Jan; 143(1):59-69. PubMed ID: 27629878
[TBL] [Abstract][Full Text] [Related]
11. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling.
Tang Y; Xiao G; Chen Y; Deng Y
Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897
[TBL] [Abstract][Full Text] [Related]
12. Calpain-2 Enhances Non-Small Cell Lung Cancer Progression and Chemoresistance to Paclitaxel via EGFR-pAKT Pathway.
Xu F; Gu J; Lu C; Mao W; Wang L; Zhu Q; Liu Z; Chu Y; Liu R; Ge D
Int J Biol Sci; 2019; 15(1):127-137. PubMed ID: 30662353
[TBL] [Abstract][Full Text] [Related]
13. MiR-4299 suppresses non-small cell lung cancer cell proliferation, migration and invasion through modulating PTEN/AKT/PI3K pathway.
Yang WB; Zhang WP; Shi JL; Wang JW
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3408-3414. PubMed ID: 29917192
[TBL] [Abstract][Full Text] [Related]
14. Cardamonin inhibits the proliferation and metastasis of non-small-cell lung cancer cells by suppressing the PI3K/Akt/mTOR pathway.
Zhou X; Zhou R; Li Q; Jie X; Hong J; Zong Y; Dong X; Zhang S; Li Z; Wu G
Anticancer Drugs; 2019 Mar; 30(3):241-250. PubMed ID: 30640793
[TBL] [Abstract][Full Text] [Related]
15. OTUB2 stabilizes U2AF2 to promote the Warburg effect and tumorigenesis via the AKT/mTOR signaling pathway in non-small cell lung cancer.
Li J; Cheng D; Zhu M; Yu H; Pan Z; Liu L; Geng Q; Pan H; Yan M; Yao M
Theranostics; 2019; 9(1):179-195. PubMed ID: 30662561
[TBL] [Abstract][Full Text] [Related]
16. PARK2 inhibits osteosarcoma cell growth through the JAK2/STAT3/VEGF signaling pathway.
Lei Z; Duan H; Zhao T; Zhang Y; Li G; Meng J; Zhang S; Yan W
Cell Death Dis; 2018 Mar; 9(3):375. PubMed ID: 29515107
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-663a is downregulated in non-small cell lung cancer and inhibits proliferation and invasion by targeting JunD.
Zhang Y; Xu X; Zhang M; Wang X; Bai X; Li H; Kan L; Zhou Y; Niu H; He P
BMC Cancer; 2016 May; 16():315. PubMed ID: 27184257
[TBL] [Abstract][Full Text] [Related]
18. Suppression of Non-Small Cell Lung Cancer Growth and Metastasis by a Novel Small Molecular Activator of RECK.
Shen J; Wang B; Zhang T; Zhu N; Wang Z; Jin J; He Y; Hu M
Cell Physiol Biochem; 2018; 45(5):1807-1817. PubMed ID: 29510387
[TBL] [Abstract][Full Text] [Related]
19. Aberrant Expression of miR-362 Promotes Lung Cancer Metastasis through Downregulation of Sema3A.
Luo D; Zhang Z; Zhang Z; Li JY; Cui J; Shi WP; Dong XW; Yuan L; Lin P; Chen ZN; Bian HJ; Wang ZL
J Immunol Res; 2018; 2018():1687097. PubMed ID: 30155491
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.
Chen W; Wang J; Liu S; Wang S; Cheng Y; Zhou W; Duan C; Zhang C
J Exp Clin Cancer Res; 2016 May; 35():76. PubMed ID: 27164951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]